Skip to main content
. 2014 May 1;23(5):373–381. doi: 10.1089/jwh.2013.4414

Table 1.

 Main Characteristics of Included Studies

Author County Baseline study dates Men Women Mean age (SD) or age range, years Outcome Mean duration, years Current drinker (Men) Current drinker (Women) Number of outcome event (%, women) Maximum adjustment available
Klatsky et al., 199225 United States (U.S.) 1978–1985 56,926 72,008 40.6 Mortality from all-cause 8.0 88.6% 81.7% 1730 (40.0) Age, race, BMI, education, marital status, smoking, coffee and tea consumption
Cullen et al ., 199320 Western Australia 1966 1,085 1,086 ≥40 Mortality from all-cause, CVD 23.0 78.5% 53.4% 436 (42.7) Age, sex, occupation, smoking, BP, probable or suspected CHD, forced expiratory volume, diabetes, cholesterol, uric acid, and treatment for hypertension.
Berberian et al., 199419 Netherlands 1975–1978 760 860 >20 Mortality from all-cause, CVD, cancer 10.0 93.2% 81.6% 55 (44.7) Age, BMI, serum cholesterol, SBP, DBP, pulse rate, cigarette smoking, and history of anti-hypertension drug use
Serdula et al., 199533 U.S. 1971–1975 3,573 4,614 59 Mortality from all-cause, IHD, Non-IHD 14.2 75.0% 59.0% 1059 (43.4) Age, race, educations, smoking status, BMI, and physical activity at baseline
Simons et al., 199634 Australia 1988–1989 1,236 1,569 >60 Mortality from all-cause 6.4 78.0% 52.0% 236 (43.6) Age, marital status, smoking status, alcohol intake, BP, diabetes status, peak expiratory flow, prior CHD, atrial fibrillation, disability, and self-rated health
Deev et al., 19988 U.S. and Russia 1972–1976;1975–1977 3,808 4,356 US: 40–69
Russia:40–59
Mortality from all-cause, CVD 13.0 89.0%, 95.3 % 79.0%, 82.0% 686 (38.8) Age, education, heart rate, total cholesterol, and BMI
Maskarinecet al., 199828 U.S. 1975–1980 13,870 13,808 >30 Mortality from all-cause, CHD 20.0 37.0% 13.0% 2016 (40.2) Age, ethnicity, years of school, BMI, and smoking status
Hoffmeister et al., 199923 Germany 1985, 1988, 1991 7,677 7,732 25–69 Mortality from all-cause, CVD 7.0 81.9% 55.5% 66 (41.5) Age, smoking, and social status
Liao et al., 200026 U.S. 1988, 1990 17,821 25,874 ≥40 Mortality from all-cause,CHD 6.0 69.0% 57.5% 2957 (53.4) Age, race, smoking status, and history of hypertension, diabetes, and heart disease, marital status, number of years of education, and self-perceived health status
Trevisan et al., 200135 Italy 1978 8,980 6,669 30–59 Mortality from all-cause, cancer 7.0 88.9% 66.3% 165 (23.7) Age and current smoking
Rehm et al., 200130 U.S. 1984 2,037 3,035 ≥18 Mortality from all-cause 11.3 72.9% 53.9% 260 (48.9) Age and ethnicity, income, marital status, smoking status
Diem et al., 200321 Swiss 1974–1977 162 125 46.2 Mortality from all-cause, CHD 12.6 66.7% 20.8% 24 (34.3) Age, duration of diabetes, BMI, cholesterol, SBP, and nicotine consumption
Sempos et al., 200332 U.S. 1971–1975 768 1,286 25–75 Mortality from all-cause 19.0 72.4% 60.0% 437 (50.9) Age, BMI, cigarette smoking, and physically very active
Wellmannet al., 200436 Southern Germany 1987–1988 1,345 1,365 38–67 Mortality from all-cause 10.0 84.0% 56.0% 84 (34.6) Age, smoking, physical activity, partner status, education, BMI, total cholesterol, and hypertension
Makela et al., 200527 Finland 1969, 1976, 1984 3481 2,913 25–69 Mortality from all-cause 15.2 88.1% 70.4% 398 (34.8) Age, period, marital status, education, and smoking status
Baglietto et al., 200618 Australia 1990–1994 14,557 22,427 40–69 Mortality from all-cause 10.5 83.0% 59.0% 654 (42.8) Country of birth, smoking, fruit and vegetable intake, total energy intake, saturated fat, physical activity, education, and BMI
Paganini-Hill et al., 200729 U.S. 1981 4,980 8,644 74 Mortality from all-cause 23.0 78.0% 72.0% 6930 (60.9) Age, smoking, exercise, BMI, caffeine consumption, and histories of hypertension, angina, heart attack, stroke, diabetes, rheumatoid arthritis, and cancer
Friesema et al., 200822 Netherland 1996 1,562 1,573 45–70 Mortality from all-cause, CVD 5.0 NA NA 204 (38.2) Age, region, smoking, BMI, fat intake, physical activity, education, income, and medical histories of CVD, hypertension, diabetes, and hypercholesterolemia
Sun et al., 20099 Hong Kong 1998–2000 18,750 37,417 >65 Mortality from all-cause 4.1 30.1% 8.9% 1988 (52.1) Age, education, housing type, BMI, and smoking status.
Sadakane et al., 200931 Japan 1992–1995 3,444 5,490 56.4 Mortality from all-cause 12.0 76.1% 24.1% 240 (37.7) Age, tobacco smoking, education level, marital status, BMI, and physical activity index
Inoue et al., 20127,* Japan 1988–1994 144,012 165,070 35–79 Mortality from all-cause, cancer, heart disease,cerebrovascular disease 12.4 77.0% 27.0% 13541 (37.8) Age and area, smoking, BMI, history of hypertension, history of diabetes, and leisure-time sports or physical exercise
Kim et al., 201024 Korea 2000 919,199 422,194 Male:49.0
Female:48.3
Mortality from all-cause, cancer 5.0 69.6% 20.3% 3267 (16.9) Age, residential, smoking status, regular exercise, BMI, SBP, DBP, and fasting blood sugar
CHEFS** (Unpublished data) China 1991 66,078 71,048 >40 Mortality from all-cause, cancer 8.3 38.5% 2.8% 7678 (43.9) Age, BMI, SBP, cigarette smoking, high school education, physical inactivity, urban or rural residence, northern or southern China, and diabetes.
China data from APCSC*** (Unpublished data) China NA 177,788 69,902 >18 Mortality from all-cause, cancer 7.5 32.6% 4.2% 2405 (27.2) Age, smoking, SBP, education
*

The pooled analyses included the JPHC-I, JPHC-II, JACC, MIYAGI, OHSAKI, and TAKAYAMA studies.

**

The design and rationale for the cohort of China National Hypertension Survey Epidemiology Follow-Up Study (CHEFS) referred to reference 17.

***

The design and rationale for the cohort of mainland China from the Asia Pacific Cohort Studies Collaboration (APCSC) referred to reference 16.

APCSC, Asia Pacific Cohort Studies Collaboration; BMI, body mass index; BP, blood pressure; CHD, coronary heart disease; CVD, cardiovascular disease; DBP, diastolic blood pressure; IHD, ischemic heart disease; NA, not applicable; SBP, systolic blood pressure; JPHC-I, Japan Public Health Center-based Prospective Study, Cohort I; JPHC-II, Japan Public Health Center-based Prospective Study, Cohort II; JACC, Japan Collaborative Cohort Study; MIYAGI, Miyagi Cohort Study; OHSAKI, Ohsaki National Health Insurance Cohort Study; TAKAYAMA, Takayama Study.